Alessandro Zannotti

Dr. Alessandro Zannotti

Department of Specialist and Odontostomatological Clinical Sciences, Università Politecnica delle Marche, 60126 Ancona, Italy - Department of Experimental and Clinical Medicine, Università Politecnica delle Marche, 60126 Ancona, Italy;
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2021 in Cells
Verified
Journal Article
Open access
PDF file
Alessandro ZannottiAlessandro Zannotti
Alessandro Zannotti
SGStefania Greco
Stefania Greco
PPPamela Pellegrino
Pamela Pellegrino
FGFederica Giantomassi
Federica Giantomassi
Giovanni Delli CarpiniGiovanni Delli Carpini
Giovanni Delli Carpini
PCPasquapina Ciarmela
Pasquapina Ciarmela
Uterine fibroids represent the most common benign tumors of the uterus. They are considered a typical fibrotic disorder. In fact, the extracellular matrix (ECM) proteins—above all, collagen 1A1, fibronectin and versican—are upregulated in this pathology. The uterine fibroids etiology has not yet been clarified, and this represents an important matter about their resolution. A model has been proposed according to which the formation of an altered ECM could be the result of an excessive wound healing, in turn driven by a dysregulated inflammation process. A lot of molecules act in the complex inflammatory response. Macrophages have a great flexibility since they can assume different phenotypes leading to the tissue repair process. The dysregulation of macrophage proliferation, accumulation and infiltration could lead to an uncontrolled tissue repair and to the consequent pathological fibrosis. In addition, molecules such as monocyte chemoattractant protein-1 (MCP-1), granulocyte macrophage-colony-stimulating factor (GM-CSF), transforming growth factor-beta (TGF-β), activin A and tumor necrosis factor-alfa (TNF-α) were demonstrated to play an important role in the macrophage action within the uncontrolled tissue repair that contributes to the pathological fibrosis that represents a typical feature of the uterine fibroids.

25 March 2018 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
MIMd Soriful Islam
Md Soriful Islam
CCClara Castellucci
Clara Castellucci
RFRosamaria Fiorini
Rosamaria Fiorini
SGStefania Greco
Stefania Greco
RGRiccardo Gagliardi
Riccardo Gagliardi
PCPasquapina Ciarmela
Pasquapina Ciarmela

22 July 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Alessandra GiulianiAlessandra Giuliani
Alessandra Giuliani
SGStefania Greco
Stefania Greco
SPSerena Pacilè
Serena Pacilè
Alessandro ZannottiAlessandro Zannotti
Alessandro Zannotti
Giovanni Delli CarpiniGiovanni Delli Carpini
Giovanni Delli Carpini
PCPasquapina Ciarmela
Pasquapina Ciarmela
Uterine leiomyoma is the most common benign smooth muscle tumor in women pelvis, originating from the myometrium. It is caused by a disorder of fibrosis, with a large production and disruption of extracellular matrix (ECM). Medical treatments are still very limited and no preventative therapies have been developed. We supposed that synchrotron-based phase-contrast microtomography (PhC-microCT) may be an appropriate tool to assess the 3D morphology of uterine leiomyoma, without the use of any contrast agent. We used this technique to perform the imaging and the quantitative morphometric analysis of healthy myometrium and pathologic leiomyomas. The quantitative morphometric analysis of collagen bundles was coupled to the Roschger approach. This method, previously only used to evaluate mineralized bone density distribution, was applied here to study the fibrosis mass density distribution in healthy and pathologic biopsies from two patients. This protocol was shown to be powerful in studying uterine leiomyomas, detecting also small signs of the ECM alteration. This is of paramount importance not only for the follow-up of the present study, i.e. the investigation of different compounds and their possible therapeutic benefits, but also because it offers new methodologic possibilities for future studies of the ECM in soft tissues of different body districts.

16 July 2022 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
ABAlessia Belloni
Alessia Belloni
Michele FurlaniMichele Furlani
Michele Furlani
SGStefania Greco
Stefania Greco
Valentina NotarstefanoValentina Notarstefano
Valentina Notarstefano
CPChiara Pro
Chiara Pro
PCPasquapina Ciarmela
Pasquapina Ciarmela

1 April 2020 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
SGStefania Greco
Stefania Greco
MIMd Soriful Islam
Md Soriful Islam
Alessandro ZannottiAlessandro Zannotti
Alessandro Zannotti
Giovanni Delli CarpiniGiovanni Delli Carpini
Giovanni Delli Carpini
SGStefano Raffaele Giannubilo
Stefano Raffaele Giannubilo
PCPasquapina Ciarmela
Pasquapina Ciarmela

30 November 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
SGStefania Greco
Stefania Greco
PPPamela Pellegrino
Pamela Pellegrino
Alessandro ZannottiAlessandro Zannotti
Alessandro Zannotti
Giovanni Delli CarpiniGiovanni Delli Carpini
Giovanni Delli Carpini
ACAndrea Ciavattini
Andrea Ciavattini
PCPasquapina Ciarmela
Pasquapina Ciarmela
In recent years, there has been an increasing interest in natural therapies to prevent or treat female diseases. In particular, many studies have focused on searching natural compounds with less side effects than standard hormonal therapies. While phytoestrogen-based therapies have been extensively studied, treatments with phytoprogestins reported in the literature are very rare. In this review, we focused on compounds of natural origin, which have progestin effects and that could be good candidates for preventing and treating female diseases. We identified the following phytoprogestins: kaempferol, apigenin, luteolin, and naringenin. In vitro studies showed promising results such as the antitumoral effects of kaempferol, apigenin and luteolin, and the anti-fibrotic effects of naringenin. Although limited data are available, it seems that phytoprogestins could be a promising tool for preventing and treating hormone-dependent diseases.